{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T20:24:38Z","timestamp":1785183878044,"version":"3.55.0"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T00:00:00Z","timestamp":1673308800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p><jats:italic>IARS2<\/jats:italic> (EC6.1.5) is a mitochondrial isoleucine-tRNA synthetase. Despite the fact that only fewer than 30 patients have been reported in the literature, mitochondrial disorders caused by pathogenic variants in the IARS2 gene (OMIM: 616007) have a very broad and variable clinical phenotype spectrum. We present a child who has sideroblastic anemia and hypoparathyroidism as a result of a previously unreported mutation in the IARS2 gene.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case presentation<\/jats:title><jats:p>A 14-year-old girl who had been anemic for 12 years was diagnosed with pure red cell aplasia (hemoglobin 42\u2005g\/L, reference range 110\u2013160) at the age of 2. Her anemia was resistant to high-dose intravenous gamma globulin and cyclosporine therapy and required monthly blood transfusions to maintain normal hemoglobin levels. She developed cataracts at the age of 6 and was cured by phacoemulsification. At the age of 8, she visited the endocrine department, because of mental and physical retardation accompanied by repeated convulsions, and the antiepileptic treatment was ineffective. She was diagnosed with hypoparathyroidism. To control the convulsions, she was given calcitriol orally as well as large doses of calcium supplements. Due to severe growth and development delays, delayed sexual development, and hypokinesia at the age of 13.5Y, the parents agreed to a whole-exon gene sequencing test. IARS2 gene compound heterozygous variants c.2450G\u2009&amp;gt;\u2009A (<jats:italic>p<\/jats:italic>.Arg817His) and c.2511del (<jats:italic>p<\/jats:italic>.Leu838Phefs*69) were discovered. The girl was then diagnosed with <jats:italic>IARS2<\/jats:italic>-related disease and given a cocktail therapy of coenzyme Q<jats:sub>10<\/jats:sub>, vitamin B<jats:sub>2<\/jats:sub>, L-Carnitine and vitamin E. Although the child's clinical symptoms improved, she still experienced intermittent claudication and hip joint pain. The vitamin B<jats:sub>6<\/jats:sub> was discontinued after three months due to its ineffectiveness in treating anemia. Because the child's ferritin levels remained elevated, she was also prescribed long-term oral deferiprone therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our findings broaden the clinical and genetic spectrum of <jats:italic>IARS2<\/jats:italic>-associated disease, and case summaries help raise clinical awareness of <jats:italic>IARS2<\/jats:italic>-associated disease and reduce under- and misdiagnosis.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fped.2022.1080664","type":"journal-article","created":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:43:38Z","timestamp":1673383418000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["IARS2-related disease manifesting as sideroblastic anemia and hypoparathyroidism: A case report"],"prefix":"10.3389","volume":"10","author":[{"given":"Yan","family":"Gong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Ping","family":"Lan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"R114","DOI":"10.1093\/hmg\/ddx231","article-title":"Emerging mechanisms of aminoacyl-tRNA synthetase mutations in recessive and dominant human disease","volume":"26","author":"Meyer-Schuman","year":"2017","journal-title":"Hum Mol Genet"},{"key":"B2","doi-asserted-by":"publisher","first-page":"787956","DOI":"10.1155\/2014\/787956","article-title":"The mitochondrial aminoacyl tRNA synthetases: genes and syndromes","volume":"2014","author":"Diodato","year":"2014","journal-title":"Int J Cell Biol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1002\/humu.22629","article-title":"Mutation in the nuclear-encoded mitochondrial isoleucyl-tRNA synthetase IARS2 in patients with cataracts, growth hormone deficiency with short stature, partial sensorineural deafness, and peripheral neuropathy or with leigh syndrome","volume":"35","author":"Schwartzentruber","year":"2014","journal-title":"Hum Mutat"},{"key":"B4","doi-asserted-by":"publisher","first-page":"e05401","DOI":"10.1002\/ccr3.5401","article-title":"Genotype-phenotype correlation in IARS2-related diseases: a case report and review of literature","volume":"10","author":"Upadia","year":"2022","journal-title":"Clin Case Rep"},{"key":"B5","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1177\/088307389300800312","article-title":"Unique hereditary sensory and autonomic neuropathy with growth hormone deficiency","volume":"8","author":"Liberfarb","year":"1993","journal-title":"J Child Neurol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1097\/ICO.0000000000000847","article-title":"Recessive mutation in a nuclear-encoded mitochondrial tRNA synthetase associated with infantile cataract, congenital neurotrophic keratitis, and orbital myopathy","volume":"35","author":"Jabbour","year":"2016","journal-title":"Cornea"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1002\/ajmg.a.38116","article-title":"Confirmation of CAGSSS syndrome as a distinct entity in a danish patient with a novel homozygous mutation in IARS2","volume":"173","author":"Moosa","year":"2017","journal-title":"Am J Med Genet A"},{"key":"B8","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.braindev.2018.06.010","article-title":"Novel IARS2 mutations in Japanese siblings with CAGSSS, leigh, and west syndrome","volume":"40","author":"Takezawa","year":"2018","journal-title":"Brain Dev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s12881-018-0709-3","article-title":"Expanding the clinical phenotype of IARS2-related mitochondrial disease","volume":"19","author":"Vona","year":"2018","journal-title":"Bmc Med Genet"},{"key":"B10","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s13023-018-0828-0","article-title":"Clinical and genetic characteristics of Chinese patients with familial or sporadic pediatric cataract","volume":"13","author":"Li","year":"2018","journal-title":"Orphanet J Rare Dis"},{"key":"B11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.5734\/jgm.2019.16.2.55","article-title":"Clinical and genetic characteristics of Korean patients with IARS2-related disorders","volume":"16","author":"Lee","year":"2019","journal-title":"J Genet Med Korean Soci of Med Genet"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.3324\/haematol.2020.270710","article-title":"Biallelic IARS2 mutations presenting as sideroblastic anemia","volume":"106","author":"Barcia","year":"2021","journal-title":"Haematologica"},{"key":"B13","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.ymgme.2021.04.004","article-title":"Phenotypic diversity of brain MRI patterns in mitochondrial aminoacyl-tRNA synthetase mutations","volume":"133","author":"Roux","year":"2021","journal-title":"Mol Genet Metab"},{"key":"B14","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fgene.2014.00142","article-title":"tRNA gene diversity in the three domains of life","volume":"5","author":"Fujishima","year":"2014","journal-title":"Front Genet"},{"key":"B15","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/nrendo.2016.151","article-title":"Mitochondrial disease and endocrine dysfunction","volume":"13","author":"Chow","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/gim.2017.107","article-title":"Patient care standards for primary mitochondrial disease: a consensus statement from the mitochondrial medicine society","volume":"19","author":"Parikh","year":"2017","journal-title":"Genet Med"},{"key":"B17","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s11689-019-9292-y","article-title":"Mitochondrial aminoacyl-tRNA synthetase disorders: an emerging group of developmental disorders of myelination","volume":"11","author":"Fine","year":"2019","journal-title":"J Neurodev Disord"},{"key":"B18","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/ped.12217","article-title":"Pathophysiology and genetic mutations in congenital sideroblastic anemia","volume":"55","author":"Fujiwara","year":"2013","journal-title":"Pediatr Int"},{"key":"B19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.gene.2018.05.074","article-title":"Congenital sideroblastic anemia: advances in gene mutations and pathophysiology","volume":"668","author":"Long","year":"2018","journal-title":"Gene"},{"key":"B20","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1542\/peds.2004-0718","article-title":"Clinical spectrum, morbidity, and mortality in 113 pediatric patients with mitochondrial disease","volume":"114","author":"Scaglia","year":"2004","journal-title":"Pediatr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1080664\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T20:43:40Z","timestamp":1673383420000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fped.2022.1080664\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,10]]},"references-count":20,"alternative-id":["10.3389\/fped.2022.1080664"],"URL":"https:\/\/doi.org\/10.3389\/fped.2022.1080664","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,10]]},"article-number":"1080664"}}